Contamination Control Compass
Edition #12/2025

Informative Articles
Monocyte Activation Test meets Digital PCR

Discover how the NAT-MAT® combines the proven Monocyte Activation Test with the precision of digital PCR, shifting detection from protein to mRNA level to capture earlier immune activation. Learn how this next-generation approach reduces hands-on time and delivers results equivalent to ELISA-based MATs – while simplifying complex workflows.

Product Highlights
2025 brought plenty of change and new solutions to help you save time, minimize risk, and stay compliant

For many of our customers, 2025 has been a year of transition.

Regulations shifted, testing standards evolved, and lab routines had to adapt.

We’ve been right there with you, following each update, preparing for what was coming, and making sure our products would keep your workflows running smoothly.

Before every new release, our teams spend months testing internally to ensure each kit meets the latest requirements. Still, only when the final text of the regulation is published can we be absolutely sure every detail aligns.

That’s when all departments come together: R&D, quality control, production, management, product management, marketing, and sales. Everyone contributes its part so that the kits reaching our customers perform exactly as expected, ready for smooth validation and routine use.

These phases can be intense, but they also create a strong sense of teamwork. And honestly, it’s a great feeling when our customers start their validation runs and we can support them directly.

Our NAT-MAT® was developed with this mindset long before the removal of the Rabbit Pyrogen Test from the European Pharmacopoeia on July 1, 2025, became official. Knowing that this change was on the horizon, we combined our expertise in nucleic acid testing with the established Monocyte Activation Test to create a fully regulatory-aligned, animal-free alternative that delivers precise, automated, and fast results.

The same spirit guided our work on the updated Venor® Mycoplasma qPCR and 100GC® Mycoplasma Standards. With the upcoming revision of chapter 2.6.7 “Mycoplasmas,” we wanted to give labs tools that not only comply with the new guidelines but also make their validation work easier and faster.

And beyond that, our MiQuant® kits for vector copy number, vector titer and host cell DNA quantification – CAR-T Cell Lenti, Residual DNA HEK-293, and AAV 2/6, 5 – now enable faster, more precise, and partly standard-curve-free analysis.

They make in-process control and final release testing more efficient and support reliable decision-making in daily lab work.

2025 reminded us that progress starts with listening and adapting – and that innovation is only meaningful when it helps you save time, minimize risk, and stay compliant.

Thank you for your trust and collaboration this year. We’re already looking forward to what we can achieve together in 2026.


Warm regards from Berlin,

Your MB Team

Stay up to date also in 2026!

Articles to browse and expand your knowledge

Stay informed about all product changes via NoC

Dates 2025: Where can you meet us in person?

Do you need technical support or have questions regarding our products? Please contact support@minerva-biolabs.com. Any feedback or suggestions? Write an email to newsletter@minerva-biolabs.com.